Miljkovic Milos 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Miljkovic Milos
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-02+703,000→ 703,000 totalExercise: $0.66Exp: 2034-01-01→ Common Stock (703,000 underlying) - Award
Common Stock
2024-01-02+548,200→ 548,200 total
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.
- [F2]This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter.